Diabetes tech company recalls some Dexcom G7 sensors 26 May 2026 The Therapeutic Goods Administration has issued a notice that AA-Med Pty Ltd is recalling two lots of Dexcom G7 sensors. The lots affected are 1725204004 and 1725069002. These lots were identified for disposal and destruction in the USA due to incomplete sterilisation and deployment failure during testing. The devices from both lots were stolen during the disposal process, and sold to third parties via unauthorised supply channels.As the supply channels for these lots cannot be established, the risk of some devices reaching the Australian market cannot be excluded. No Dexcom G7 sensors received through the NDSS will be impacted by the recall.The TGA advised that if you have any of the affected products, immediately discontinue use and dispose of them. For more information, please refer to the market action alert on the TGA website.
News 19 June 2026 Diabetes Australia strengthens lived experience voices with revised Constitution Everything Diabetes Australia does – every investment, every policy, every service – is to support our diabetes community. Today, Diabetes... Continue Reading
Media releases 18 June 2026 Hope for Australians living with cystic fibrosis and diabetes as new research targets breakthrough treatment A leading diabetes and respiratory researcher is investigating whether a breakthrough cystic fibrosis treatment could change the course of a serious form of diabetes affecting Australians living with cystic fibrosis. Continue Reading
Partners 1 June 2026 Does your CGM meet anzCGM standards? Advertisement When you live with diabetes, glucose readings influence everyday choices: from food and exercise to conversations with your healthcare... Continue Reading